CFDE Data Portal | Search TEX41

	Label	Description
	TEX41 associations Collection (Entity type)	Associations for TEX41_associations
	TEX41 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	TEX41 Gene (Entity type)	ENSG00000226674 - testis expressed 41
	GSE213588 trametinib NF1 8 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE176366 vincristine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE142357 HDAC3 inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

TEX41 associations

Associations for TEX41_associations

TEX41 associations.tsv

A file from IDG as part of the Harmonizome project

TEX41

ENSG00000226674 - testis expressed 41

GSE213588 trametinib NF1 8 v 11 human up

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 0 v 1 human dn

A Gene Set from LINCS

GSE176366 vincristine 3 v 2 human dn

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 2 human up

A Gene Set from LINCS

GSE216043 cisplatin 11 v 1 human dn

A Gene Set from LINCS

GSE142357 HDAC3 inhibition 1 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.